NovaBay Pharmaceuticals News - NBY

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
NovaBay Pharmaceuticals Inc New NBY AMEX Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.018 -2.93% 0.597 0.6259 0.5851 0.601 0.615 19:21:46
more quote information »

Recent News

Date Time Source Heading
10/21/20196:46IHNWFeaturedWhen it comes to championing older, established care homes, RB Care Homes are at the forefront of the advocacy.
10/10/201916:31EDGARCurrent Report Filing (8-k)
9/24/201906:50BWNovaBay Pharmaceuticals Receives Approval for Distribution..
9/16/201916:31EDGARCurrent Report Filing (8-k)
9/16/201906:50BWNovaBay Pharmaceuticals Names Finance Executive Jeff Zheng..
9/13/201908:31EDGARProxy Statement (definitive) (def 14a)
9/13/201906:01EDGARNotice of Effectiveness (effect)
9/04/201916:33EDGARSecurities Registration Statement (simplified Form) (s-3)
9/03/201906:50BWNovaBay Pharmaceuticals to Present at Two Investment..
8/30/201916:31EDGARProxy Statement - Notice of Shareholders Meeting..
8/26/201914:12EDGARSmall Company Offering and Sale of Securities Without..
8/26/201914:06EDGARSmall Company Offering and Sale of Securities Without..
8/19/201917:14EDGARStatement of Ownership (sc 13g)
8/15/201913:29EDGARStatement of Ownership (sc 13g)
8/13/201916:31EDGARCurrent Report Filing (8-k)
8/09/201917:03EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/09/201909:02EDGARCurrent Report Filing (8-k)
8/07/201908:01EDGARCurrent Report Filing (8-k)
8/07/201906:54EDGARQuarterly Report (10-q)
8/07/201906:50BWNovaBay Pharmaceuticals Reports 2019 Second Quarter..
8/06/201908:19EDGARStatement of Changes in Beneficial Ownership (4)
8/01/201906:01EDGARNotice of Effectiveness (effect)
7/29/201908:31EDGARCurrent Report Filing (8-k)
7/29/201906:50BWNovaBay Pharmaceuticals Reports 2019 Second Quarter Net..
7/26/201917:02EDGARSecurities Registration Statement (simplified Form) (s-3)
7/25/201916:31EDGARCurrent Report Filing (8-k)
7/15/201908:31EDGARCurrent Report Filing (8-k)
7/15/201906:50BWNovaBay Pharmaceuticals Issues Letter to Stockholders
7/03/201914:27EDGARSmall Company Offering and Sale of Securities Without..
7/01/201908:33EDGARCurrent Report Filing (8-k)
7/01/201906:50BWNovaBay Pharmaceuticals Plan of Compliance Accepted by NYSE
6/26/201916:32EDGARCurrent Report Filing (8-k)
6/26/201916:05BWNovaBay Pharmaceuticals Raises $2.4 Million in a Private..
6/19/201908:30EDGARCurrent Report Filing (8-k)
6/17/201908:32EDGARCurrent Report Filing (8-k)
6/17/201906:50BWNovaBay Pharmaceuticals Appoints Justin Hall President and..
6/13/201906:06EDGARStatement of Changes in Beneficial Ownership (4)
6/10/201906:50BWNovaBay Pharmaceuticals Launches Avenova® Direct on..
6/03/201916:33EDGARCurrent Report Filing (8-k)
5/21/201916:51EDGARCurrent Report Filing (8-k)
5/21/201916:05BWNovaBay Pharmaceuticals Receives NYSE American Communication
5/15/201915:06EDGARQuarterly Report (10-q)
5/13/201916:32EDGARCurrent Report Filing (8-k)
5/09/201916:05BWNovaBay Pharmaceuticals Reports First Quarter 2019 Financial..
5/03/201916:54EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/03/201916:34EDGARCurrent Report Filing (8-k)
4/30/201906:50BWNovaBay Pharmaceuticals to Hold First Quarter 2019..
4/19/201916:38EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/19/201916:33EDGARProxy Statement (definitive) (def 14a)
4/17/201906:50BWNovaBay Pharmaceuticals Announces Annual Meeting of..
4/16/201916:32EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
See more news about this stock »


Your Recent History
AMEX
NBY
NovaBay Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.